Literature DB >> 23296186

Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI.

M L J Schouw1, A M Kaag, M W A Caan, D F R Heijtel, C B L M Majoie, A J Nederveen, J Booij, L Reneman.   

Abstract

Pharmacological magnetic resonance imaging (phMRI) maps the neurovascular response to a pharmacological challenge and is increasingly used to assess neurotransmitter systems. Here we investigated the hemodynamic response to a dopaminergic (DAergic) challenge with dextroamphetamine (dAMPH) in humans using arterial spin labeling (ASL) based phMRI. Twelve healthy male subjects aged 21.0years (±1.5) were included. We used a pseudo-continuous ASL sequence (40min) to quantify cerebral blood flow (CBF) and started dAMPH infusion (0.3mg/kg) after 10min. On another day, we measured baseline dopamine D2/3 receptor availability with [(123)I]IBZM single photon emission computed tomography (SPECT). Baseline measures on mood and impulsivity and subjective behavioral responses to dAMPH were obtained. CBF response was corrected for cardiovascular effects using an occipital cortex mask for internal reference. Corrected CBF (sCBF) was analyzed using ROI-based and voxel-based analysis, in addition to independent component analysis (ICA). CBF data was correlated to D2/3 receptor availability and behavioral measures. Subjects reported experiencing euphoria following dAMPH administration. In the striatum sCBF significantly increased, as demonstrated by all three analysis methods. Voxel-based analysis and ICA also showed increased sCBF in the thalamus, anterior cingulate and cerebellum. Decreased sCBF was observed in several cortical areas, the posterior cingulated and paracingulate cortex. Apart from one ICA component, no correlations were found with sCBF changes and D2/3 receptor availability and behavioral measures. Our observations are in line with literature and provide further evidence that ASL-based phMRI with dAMPH is a promising technique to assess DAergic function in human subjects.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296186     DOI: 10.1016/j.neuroimage.2012.12.056

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  10 in total

1.  Dopaminergic system dysfunction in recreational dexamphetamine users.

Authors:  Anouk Schrantee; Lena Václavů; Dennis F R Heijtel; Matthan W A Caan; Willy Gsell; Paul J Lucassen; Aart J Nederveen; Jan Booij; Liesbeth Reneman
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

2.  Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease.

Authors:  Paula Trujillo; Nelleke C van Wouwe; Ya-Chen Lin; Adam J Stark; Kalen J Petersen; Hakmook Kang; David H Zald; Manus J Donahue; Daniel O Claassen
Journal:  Cortex       Date:  2019-01-29       Impact factor: 4.027

Review 3.  Use of magnetic resonance imaging in pharmacogenomics.

Authors:  Roberto Viviani; Marie-Louise Lehmann; Julia C Stingl
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 4.  The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.

Authors:  Stephen V Faraone
Journal:  Neurosci Biobehav Rev       Date:  2018-02-08       Impact factor: 8.989

Review 5.  Data collection and analysis strategies for phMRI.

Authors:  Joseph B Mandeville; Christina H Liu; Wim Vanduffel; John J A Marota; Bruce G Jenkins
Journal:  Neuropharmacology       Date:  2014-03-05       Impact factor: 5.250

Review 6.  The role of fMRI in drug development.

Authors:  Owen Carmichael; Adam J Schwarz; Christopher H Chatham; David Scott; Jessica A Turner; Jaymin Upadhyay; Alexandre Coimbra; James A Goodman; Richard Baumgartner; Brett A English; John W Apolzan; Preetham Shankapal; Keely R Hawkins
Journal:  Drug Discov Today       Date:  2017-11-15       Impact factor: 7.851

7.  Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa.

Authors:  Stefanie Verena Mueller; Yosuke Morishima; Simon Schwab; Roland Wiest; Andrea Federspiel; Gregor Hasler
Journal:  Neuropsychopharmacology       Date:  2017-11-06       Impact factor: 7.853

8.  The Effects of Methylphenidate on Resting-State Functional Connectivity of the Basal Nucleus of Meynert, Locus Coeruleus, and Ventral Tegmental Area in Healthy Adults.

Authors:  Ryan L Kline; Sheng Zhang; Olivia M Farr; Sien Hu; Laszlo Zaborszky; Gregory R Samanez-Larkin; Chiang-Shan R Li
Journal:  Front Hum Neurosci       Date:  2016-04-18       Impact factor: 3.169

9.  Cerebral blood flow predicts differential neurotransmitter activity.

Authors:  Juergen Dukart; Štefan Holiga; Christopher Chatham; Peter Hawkins; Anna Forsyth; Rebecca McMillan; Jim Myers; Anne R Lingford-Hughes; David J Nutt; Emilio Merlo-Pich; Celine Risterucci; Lauren Boak; Daniel Umbricht; Scott Schobel; Thomas Liu; Mitul A Mehta; Fernando O Zelaya; Steve C Williams; Gregory Brown; Martin Paulus; Garry D Honey; Suresh Muthukumaraswamy; Joerg Hipp; Alessandro Bertolino; Fabio Sambataro
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

10.  Evaluation of drug effects on cerebral blood flow and glucose uptake in un-anesthetized and un-stimulated rats: application of free-moving apparatus enabling to keep rats free during PET/SPECT tracer injection and uptake.

Authors:  Taku Sugita; Yusuke Kondo; Seigo Ishino; Ikuo Mori; Takashi Horiguchi; Mikako Ogawa; Yasuhiro Magata
Journal:  Nucl Med Commun       Date:  2018-08       Impact factor: 1.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.